Small molecule inhibitors limit endothelial cell invasion by staphylococcus aureus

Current Pharmaceutical Biotechnology

Volumn 15, Issue 8, 2014, Pages 727-737

  Cordero, Diana ^a   Fullenkamp, Christopher R ^a   Pelly, Rachel R ^a   Reed, Katie M ^a   Caffo, Lindy M ^a   Zahrt, Ashley N ^a   Newman, Micaleah ^a   Komanapalli, Sarah ^a   Niemeier, Evan M ^a   Bishop, Derron L ^b   Bruns, Heather A ^a   Haynes, Mark K ^c   Sklar, Larry A ^c   Sammelson, Robert E ^a   McDowell, Susan A ^a  

^a BALL STATE UNIVERSITY   (United States)

^b BALL STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

CDC42; Fibronectin; ML 141; MRSA; MSSA; Pyrazolines; Sepsis

Indexed keywords

4 [3 (4 METHOXYPHENYL) 5 PHENYL 3,4 DIHYDROPYRAZOL 2 YL]BENZENESULFONAMIDE; ACTIN; CHALCONE; ENZYME INHIBITOR; FIBRONECTIN; PROTEIN CDC42; UNCLASSIFIED DRUG; CDC42BPA PROTEIN, HUMAN; MOLECULAR LIBRARY; MYOTONIC DYSTROPHY PROTEIN KINASE;

ALKYLATION; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CELL INVASION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY ASSAY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC50; IMMUNOFLUORESCENCE; NONHUMAN; PROTEIN FUNCTION; RESPONSE SURFACE METHOD; STAPHYLOCOCCUS AUREUS; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; ANTAGONISTS AND INHIBITORS; BACTERIUM ADHERENCE; CELL CULTURE; DRUG EFFECTS; MICROBIOLOGY; MOLECULAR LIBRARY; PHARMACOLOGY;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

BACTERIAL ADHESION; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MYOTONIN-PROTEIN KINASE; SMALL MOLECULE LIBRARIES; STAPHYLOCOCCUS AUREUS;

EID: 84925850064     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666140909124310     Document Type: Article

References (35)

1. Ray, G.T.; Suaya, J.A.; Baxter R. Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization. J. Clin. Microbiol., 2012, 50(6), 1950-1957.
2. Dantes, R.; Mu, Y.; Belflower, R.; Aragon, D.; Dumyati, G.; Harrison, L.H.; Lessa, F.C.; Lynfield, R.; Nadle, J.; Petit, S.; Ray, S.M.; Schaffner, W.; Townes, J.; Fridkin, S. Emerging Infections Program-Active Bacterial Core Surveillance M.S.I. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern. Med., 2013, 173(21), 1970-1978.
3. Mongkolrattanothai, K.; Aldag, J.C.; Mankin, P.; Gray, B.M. Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: An experience at a Children's Hospital in central Illinois. BMC. Infect. Dis., 2009, 9(112).
4. David, M.Z.; Boyle-Vavra, S.; Zychowski, D.L.; Daum, R.S. Methicillin-susceptible Staphylococcus aureus as a predominantly healthcare-associated pathogen: A possible reversal of roles. PLoS. One., 2011, 6(4), e18217.
5. Shorr, A.F.; Haque, N.; Taneja, C.; Zervos, M.; Lamerato, L.; Kothari, S.; Zilber, S.; Donabedian, S.; Perri, M.B.; Spalding, J.; Oster, G. Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J. Clin. Microbiol., 2010, 48(9), 3258-3262.
6. Khatib, R.; Sharma, M.; Iyer, S.; Fakih, M.G.; Obeid, K.M.; Venugopal, A.; Fishbain, J.; Johnson, L.B.; Segireddy, M.; Jose, J.; Riederer, K. Decreasing incidence of Staphylococcus aureus bacteremia over 9 years: Greatest decline in community-associated methicillin-susceptible and hospital-acquired methicillin-resistant isolates. Am. J. Infect. Control, 2013, 41(3), 210-213.
7. Melzer, M.;Welch, C. Thirty-day mortality in UK patients with community-onset and hospital-acquired meticillin-susceptible Staphylococcus aureus bacteraemia. J. Hosp. Infect., 2013, 84(2), 143-150.
8. Loffler, B.; Tuchscherr, L.; Niemann, S.; Peters, G. Staphylococcus aureus persistence in non-professional phagocytes. Int. J. Med. Microbiol., 2014, 304(2), 170-176.
9. Foster, T.J.; Geoghegan, J.A.; Ganesh, V.K.; Hook M. Adhesion, invasion and evasion: The many functions of the surface proteins of Staphylococcus aureus. Nat. Rev. Microbiol., 2014, 12(1), 49-62.
10. Edwards, A.M.; Massey, R.C. How does Staphylococcus aureus escape the bloodstream. Trends Microbiol., 2011, 19(4), 184-190.
11. Lowy, F.D. Staphylococcus aureus infections. N. Engl. J. Med., 1998, 339(8), 520-532.
12. Molinari, G.; Rohde, M.; Wilde, C.; Just, I.; Aktories, K.; Chhatwal, G.S. Localization of the C3-Like ADPribosyltransferase from Staphylococcus aureus during bacterial invasion of mammalian cells. Infect. Immun., 2006, 74(6), 3673-3677.
13. Que, Y.A.; Moreillon, P. Infective endocarditis. Nat. Rev. Cardiol., 2011, 8(6), 322-336.
14. Edwards, A.M.; Potts, J.R.;Josefsson E.; Massey R.C. Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog., 2010, 6(6), e1000964.
15. Garzoni, C.; Kelley, W.L. Staphylococcus aureus: New evidence for intracellular persistence. Trends. Microbiol., 2009, 17(2), 59-65.
16. Horn, M.P.; Knecht, S.M.; Rushing, F.L.; Birdsong, J.; Siddall, C.P.; Johnson, C.M.; Abraham, T.N.; Brown, A.; Volk, C.B.; Gammon, K.; Bishop, D.L.; McKillip, J.L.; McDowell, S.A. Simvastatin inhibits Staphylococcus aureus host cell invasion through modulation of isoprenoid intermediates. J. Pharmacol. Exp. Ther., 2008, 326(1), 135-143.
17. Agerer, F.; Michel, A.; Ohlsen, K.; Hauck, C.R. Integrin-mediated invasion of Staphylococcus aureus into human cells requires Src family protein-tyrosine kinases. J. Biol. Chem., 2003, 278(43), 42524-42531.
18. McDowell, S.A.; Ma, Y.; Kusano, R.; Akinbi, H.T. Simvastatin is protective during Staphylococcus aureus pneumonia. Curr. Pharma. Biotechnol., 2011, 12(1455-62).
19. Zhang, F.L.; Casey, P.J. Protein prenylation: Molecular mechanisms and functional consequences. Annu. Rev. Biochem., 1996, 65(241-69).
20. Nobes, C.D.; Hall, A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell, 1995, 81(1), 53-62.
21. Hong, L.; Kenney, S.R.; Phillips, G.K.; Simpson, D.; Schroeder, C.E.; Noth, J.; Romero, E.; Swanson, S.; Waller, A.; Strouse, J.J.; Carter, M.; Chigaev, A.; Ursu, O.; Oprea, T.; Hjelle, B.; Golden, J.E.; Aube, J.; Hudson, L.G.; Buranda, T.; Sklar, L.A.; Wandinger-Ness A. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. J. Biol. Chem., 2013, 288(12), 8531-8543.
22. Zurab, S.; Anna, W.; Jacob, S.; Cristian, B.; Oleg, U.; Virginia, S.; John, F.P.; Genevieve, K.P.; Elsa, R.; Angela, W.N.; Larry, A.S. Chad Schroeder, Denise Simpson, Julica Nöth, Jenna Wang, Jennifer Golden, and Jeffrey Aubé. A Potent and Selective Inhibitor of Cdc42 GTPase. 2010 Feb 27 [Updated 2010 Dec 16]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010.
23. Bashir, R.; Ovais, S.; Yaseen, S.; Hamid, H.; Alam, M.S.; Samim, M.; Singh, S.; Javed, K. Synthesis of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and antiinflammatory agents. Bioorgan. Medicinal Chem. Lett., 2011, 21(14), 4301-4305.
24. Soliman, R. Preparation and antidiabetic activity of some sulfonylurea derivatives of 3,5-disubstituted pyrazoles. J. Medicinal Chem., 1979, 22(3), 321-325.
25. Robinson, T.P.; Hubbard, R.B.; Ehlers, T.J.; Arbiser, J.L.; Goldsmith, D.J.; Bowen, J.P. Synthesis and biological evaluation of aromatic enones related to curcumin. Bioorg. Med. Chem., 2005, 13(12), 4007-4013.
26. Cox, C.D.; Breslin, M.J.; Mariano, B.J. Two-step synthesis of betaalkyl chalcones and their use in the synthesis of 3,5-diaryl-5-alkyl-4,5-dihydropyrazoles. Tetrahedron Lett., 2004, 45(7), 1489-1493.
27. Xin, L.; Chen, Y.Z.; Niu, L.Y.; Wu, L.Z.; Tung, C.H.; Tong, Q.X.; Yang, Q.Z. A selective turn-on fluorescent probe for Cd2+ based on a boron difluoride beta-dibenzoyl dye and its application in living cells. Organic Biomole. Chem., 2013, 11(18), 3014-3019.
28. Hauck, C.R.; Ohlsen, K. Sticky connections: Extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr. Opin. Microbiol., 2006, 9(1), 5-11.
29. Klein, I.K.; Predescu, D.N.; Sharma, T.; Knezevic, I.; Malik, A.B.; Predescu, S. Intersectin-2L regulates caveola endocytosis secondary to Cdc42-mediated actin polymerization. J. Biol. Chem., 2009, 284(38), 25953-25961.
30. Yang, L.; Wang, L.; Zheng, Y. Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts. Mol. Biol. Cell., 2006, 17(11), 4675-4685.
31. Sipes, N.S.; Feng, Y.; Guo, F.; Lee, H.O.; Chou, F.S.; Cheng, J.; Mulloy, J.; Zheng, Y. Cdc42 regulates extracellular matrix remodeling in three dimensions. J. Biol. Chem., 2011, 286(42), 36469-36477.
32. Reymond, N.; Im, J.H.; Garg, R.;Vega, F.M.; Borda, d'Agua, B.; Riou, P.; Cox, S.; Valderrama, F.; Muschel, R.J.; Ridley, A.J. Cdc42 promotes transendothelial migration of cancer cells through beta1 integrin. J. Cell Biol., 2012, 199(4), 653-668.
33. Schorey, J.S.; Li, Q.; McCourt, D.W.; Bong-Mastek, M.; Clark-Curtiss, J.E.; Ratliff, T.L.; Brown, E.J. A Mycobacterium leprae gene encoding a fibronectin binding protein is used for efficient invasion of epithelial cells and Schwann cells. Infect. Immun., 1995, 63(7), 2652-2657.
34. van Putten, J.P.; Duensing, T.D.; Cole, R.L. Entry of OpaA+ gonococci into HEp-2 cells requires concerted action of glycosaminoglycans, fibronectin and integrin receptors. Mol. Microbiol., 1998, 29(1), 369-79.
35. Cue, D.; Dombek, P.E.; Lam, H.; Cleary, P.P. Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells. Infect. Immun., 1998, 66(10), 4593-4601.